NeuroPace Inc
NPCE· Nasdaq
Filed Jun 3, 2021 · 10-Q · 64 days after period end · 0001528287-21-000006
| Metric | Q1 2021 | Q1 2020 |
|---|---|---|
| Revenue | $11.22M | $9.98M |
| Net Income | -$8.81M | -$6.74M |
| EPS Diluted | -$32.73 | -$33.32 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NeuroPace Inc · CIK 1528287 · Engraved from SEC EDGAR
ended Mar 31, 2021 · filed Jun 3, 2021 · 64 d after period end